Matthew Norwood - Net Worth and Insider Trading
Matthew Norwood Net Worth
The estimated net worth of Matthew Norwood is at least $101 dollars as of 2024-04-20. Matthew Norwood is the VP of Sales of Obalon Therapeutics Inc and owns about 33 shares of Obalon Therapeutics Inc (OBLN) stock worth over $101. Details can be seen in Matthew Norwood's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew Norwood has not made any transactions after 2016-10-12 and currently still holds the listed stock(s).
Transaction Summary of Matthew Norwood
Matthew Norwood Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Norwood owns 2 companies in total, including Obalon Therapeutics Inc () , and Reshape Lifesciences Inc () .
Click here to see the complete history of Matthew Norwood’s form 4 insider trades.
Insider Ownership Summary of Matthew Norwood
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Obalon Therapeutics Inc | 2018-01-02 | VP of Sales | |
| Reshape Lifesciences Inc | 2016-10-05 | VP of Sales |
Matthew Norwood Latest Holdings Summary
Matthew Norwood currently owns a total of 1 stock. Matthew Norwood owns 33 shares of Obalon Therapeutics Inc (OBLN) as of October 12, 2016, with a value of $101.
Latest Holdings of Matthew Norwood
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OBLN | Obalon Therapeutics Inc | 2016-10-12 | 33 | 3.05 | 101 |
Holding Weightings of Matthew Norwood
Matthew Norwood Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Norwood has made a total of 0 transactions in Obalon Therapeutics Inc (OBLN) over the past 5 years. The most-recent trade in Obalon Therapeutics Inc is the acquisition of 33 shares on October 12, 2016, which cost Matthew Norwood around $15,000.
Insider Trading History of Matthew Norwood
- 1
Matthew Norwood Trading Performance
GuruFocus tracks the stock performance after each of Matthew Norwood's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Norwood is -33.69%. GuruFocus also compares Matthew Norwood's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Norwood within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew Norwood's insider trading performs compared to the benchmark.
Performance of Matthew Norwood
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -26.94 | -33.69 | -23.99 | -29.09 | -58.74 | -77.09 |
| Relative Return to S&P 500(%) | -28.12 | -39.83 | -33.61 | -48.34 | -72.47 | -88.66 |
Matthew Norwood Ownership Network
Ownership Network List of Matthew Norwood
Ownership Network Relation of Matthew Norwood
Matthew Norwood Owned Company Details
What does Obalon Therapeutics Inc do?
Who are the key executives at Obalon Therapeutics Inc?
Matthew Norwood is the VP of Sales of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include director & President & CEO & Exec Chairman Andrew P Rasdal , Chief Financial Officer Nooshin Hussainy , and Chief Technology Officer Mark Brister .
Obalon Therapeutics Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Obalon Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Obalon Therapeutics Inc Insider Transactions
Matthew Norwood Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Norwood. You might contact Matthew Norwood via mailing address: C/o Obalon Therapeutics, Inc., 5421 Avenida Encinas, Suite F, Carlsbad Ca 92008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
